Clinical Trial Update: A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M [Phase 2]

View source ↗

Summary

Phase 2a randomized trial of IBD98-M in ulcerative colitis completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• IBD98-M

Snippet

Sponsor: Holy Stone Healthcare Co., Ltd | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2020-08-14